Português
中文繁體中文EnglishFrançaisDeutsch日本語PortuguêsEspañolالعربيةРусскийBahasa IndonesiaไทยTiếng ViệtBahasa Melayu
Farmacia KESHAV KESHAV
Oferta do dia Popular Carrinho (0)
NEWS DETAIL

🎉 โนวาร์ติส Tafilab® ผสมกับ Majinin® ได้รับอนุมัติสำหรับข้อบ่งชี้ใหม่ #GenscriptBio# #BioinformationLittleG# เมื่อวันที่ 10 มิถุนายน โนวาร์ติสประกาศว่า Tafilab® (แคปซูล dabrafenib mesylate) ที่ผสมกับ Majinin® (ยาเม็ด trametinib) ได้รับการอนุมัติจากสำนักงานบริหารผลิตภัณฑ์ทางการแพทย์แห่งชาติ (National Medical Products Administration) สำหรับการรักษาผู้ป่วยที่มีการกลายพันธุ์ BRAF V600E ที่ไม่ตอบสนองต่อการรักษาด้วยไอโอดีนกัมมันตรังสี และไม่ตอบสนองต่อยาต้านเอนไซม์ไทโรซีนไคเนสของปัจจัยการเจริญเติบโตของหลอดเลือด (vascular endothelial growth factor tyrosine kinase inhibitors) – Sina.com

🎉【诺华泰菲乐®联合迈吉宁®获批新适应症】 #金斯瑞生物# #生物资讯小G者# 6月10日，诺华宣布其泰菲乐®（甲磺酸达拉非尼胶囊）联合迈吉宁®（曲美替尼片）获国家药监局批准，用于治疗BRAF V600E突变阳性、放射性碘难治且血管内皮生长因子酪氨酸激酶抑制剂治 新浪网

ข้อมูลทางการแพทย์

该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

Produtos relacionados com este artigo

Estes produtos foram associados automaticamente a partir do titulo, resumo e conteudo do artigo.

Lucius Trametinibe – Compre Online

Lucius Trametinibe – Compre Online

EUR 156.00
O trametinibe é um inibidor reversível das quinases 1 e 2 reguladas por sinal extracelular ativado por mitógeno (MEK1 e MEK2). Ele inibe a proliferação e metástase de células cancerígenas ao suprimir a atividade da proteína MEK e bloquear a via de sinalização MAPK.
Ver produto
DABRADX Dabrafenib 75mg

DABRADX Dabrafenib 75mg

EUR 303.33
O dabrafenibe é um medicamento oncológico inibidor da BRAF, disponível na forma de mesilato. Em 29 de maio de 2013, a Food and Drug Administration (FDA) dos EUA aprovou simultaneamente os pedidos de comercialização do dabrafenibe e do trametinibe. O dabrafenibe é aprovado para o tratamento de melanoma irressecável (tumores que não podem ser removidos cirurgicamente) e melanoma metastático (tumores que se disseminaram para outros órgãos) com a mutação BRAF V600E, mas não para o tratamento de melanoma com BRAF selvagem. O trametinibe é usado para tratar melanomas com BRAF V600E ou V600...
Ver produto
TRAMEDX Trametinibe 2 mg

TRAMEDX Trametinibe 2 mg

EUR 156.00
O trametinibe é um inibidor de MEK com atividade antitumoral, inibindo MEK1 e MEK2. Foi aprovado para comercialização pela Food and Drug Administration (FDA) dos EUA em 2013. Anormalidades na cascata de sinalização Ras/Raf/MEK/ERK estão intimamente relacionadas a tumores. Por exemplo, mutações em BRAFV600 levam à ativação persistente dessa via. O trametinibe afeta principalmente a via de sinalização MAPK, atuando sobre as proteínas MEK e, assim, inibindo a proliferação celular.
Ver produto

Perguntas frequentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Trametinibe – Compre Online Lucius Dabrafenib – Compre online DABRADX Dabrafenib 75mg TRAMEDX Trametinibe 2 mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat